Select Medical goes private in founder-led buyout

Overview

Updated Jul 1

Select Medical went public in 2001, private in 2005, and public again in 2009. On July 1, 2026, it went private a second time. Its stock stopped trading and left the New York Stock Exchange the same day.

The buyers are insiders. Co-founder Robert Ortenzio and finance chief Martin Jackson teamed with Welsh, Carson, Anderson & Stowe, the same firm that owned Select Medical last time. Public shareholders got $16.50 a share in cash, a deal worth about $3.9 billion. The company now answers to private owners.

Why it matters

Select Medical runs rehab and long-term hospitals used by hundreds of thousands of patients; those facilities now answer to private owners, not public markets.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$3.9B

Deal value

Enterprise value of the take-private transaction.

$16.50

Cash price per share

What public shareholders received for each share.

~18%

Premium to unaffected price

Markup over the share price before the deal became public.

~1,900

Outpatient rehab clinics

Clinics Select Medical runs, alongside its inpatient hospitals.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

People Involved

Robert A. Ortenzio

Executive Chairman and Co-Founder, Select Medical

Leading the buyout consortium; rolled his shares into the private company

Martin F. Jackson

Senior Executive Vice President, Strategic Finance and Operations, Select Medical

Co-leading the buyout; rolled his equity into the private company

Organizations Involved

Select Medical Holdings Corporation

Healthcare Operator

Acquired and taken private on July 1, 2026

A Pennsylvania-based operator of rehabilitation hospitals, long-term acute-care hospitals, and outpatient clinics.

Welsh, Carson, Anderson & Stowe

Private-Equity Firm

Lead outside investor in the buyout consortium

A private-equity firm focused on health care and technology that has now owned Select Medical twice.

Timeline

November 2024 July 2026

4 events Latest: July 1st, 2026 · 2 months ago

Tap a bar to jump to that date

July 2026
Buyout closes; stock leaves the NYSE
Latest Deal Completion

The merger takes effect. Select Medical's shares stop trading and the company is delisted from the New York Stock Exchange, becoming privately held.
July 1st, 2026 • 12:01 AM
June 2026
Law firm opens investigation into the board
Legal

Shareholder law firm Johnson Fistel announces an investigation into whether Select Medical's board met its duties in approving the take-private price.
June 10th, 2026
March 2026
Founders and Welsh Carson agree to buy the company
Deal Announcement

A consortium led by Robert Ortenzio, Martin Jackson, and Welsh Carson agrees to buy Select Medical at $16.50 a share. An independent committee, advised by Goldman Sachs, backed the price.
March 2nd, 2026
November 2024
Select Medical spins off Concentra
Corporate Action

Select Medical completes the spin-off of Concentra, its occupational-health arm, into a separate public company. That leaves a focused hospital and rehab business.
November 25th, 2024

Scenarios

Shareholder suits fizzle; the $16.50 price stands

Likely Resolves by End of 2027

Discussed by: Shareholder law firms including Johnson Fistel; Delaware deal-litigation trackers

Investigations into the board's approval turn into routine deal litigation that goes nowhere. Courts find the independent committee and the Goldman Sachs fairness opinion did their job. Any settlement is small and does not change what shareholders received. This is the common path for insider-led buyouts that clear a special committee.

Court forces a higher payout

Unlikely Resolves by Jul 1, 2028

Discussed by: Shareholder plaintiffs' firms; appraisal-focused investors

Dissenting shareholders press an appraisal or breach-of-duty case and win. A judge decides $16.50 undervalued the company and sets a higher fair value, or a settlement pays shareholders meaningfully more. Insider buyouts draw this scrutiny because the buyers sat on both sides of the table.

Owners take Select Medical public again

Possible Resolves by Jul 1, 2031

Discussed by: Private-equity analysts noting the firm's 2005-to-2009 round trip

History repeats. After cutting costs, refinancing debt, or reshaping the hospital footprint, the founders and Welsh Carson return Select Medical to the stock market or sell it to another buyer. Welsh Carson did exactly this last time, re-listing the company in 2009. Private-equity owners usually seek an exit within about five to seven years.

New owners expand through debt-funded acquisitions

Possible Resolves by Jul 1, 2028

Discussed by: Healthcare M&A analysts; ratings agencies watching hospital-operator leverage

Freed from quarterly reporting, the private owners borrow to buy more hospitals or clinics and grow the network. Take-privates often load companies with debt to fund expansion. Watch for new bond issuance or announced deals adding facilities to Select Medical's footprint.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

February 2005 – 2009

Select Medical's first take-private (2005–2009)

Welsh Carson led a buyout worth roughly $2.3 billion that took Select Medical private in 2005. The Ortenzio family stayed in charge. Four years later, the owners brought the company back to the public markets in a new stock offering.

Then

The company left the stock exchange and operated under private ownership for several years.

Now

The 2009 re-listing let Welsh Carson and the founders realize value, then keep running the business.

Why this matters now

The 2026 deal reunites the same founders and the same private-equity firm. The last round trip ended with a return to public markets, which shapes what investors expect this time.

November 2006 – March 2011

HCA's leveraged buyout and return (2006–2011)

A group including KKR, Bain Capital, and the founding Frist family took hospital giant HCA private in a roughly $33 billion buyout, then one of the largest ever. HCA carried heavy debt through the deal. It returned to public markets in a 2011 stock offering.

Then

HCA operated privately with a large debt load while continuing to run its hospitals.

Now

The 2011 IPO produced large gains for its owners and became a model for hospital buyouts.

Why this matters now

HCA shows the insider-plus-private-equity pattern in health care: founders stay in control, debt funds the deal, and a later re-listing is the usual goal.

February 2013 – December 2018

Dell's founder-led take-private (2013–2018)

Michael Dell and Silver Lake took Dell private in a roughly $24 billion buyout after a public fight over the price. Some shareholders argued the offer was too low. A Delaware court later found the deal had undervalued the company.

Then

Dell went private and reshaped its business away from public scrutiny.

Now

Dell returned to the stock market in 2018, and the appraisal ruling became a warning about insider buyout pricing.

Why this matters now

Dell shows the legal risk when insiders buy their own company. It is the pattern the Select Medical shareholder investigations are testing.